| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/08/2005 | US20050272780 Small molecule inhibitors of rotamase enzyme activity |
| 12/08/2005 | US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent |
| 12/08/2005 | US20050272760 Use of pyridoindolone derivatives for the preparation of medicinal products |
| 12/08/2005 | US20050272755 Method for treating abnormal cell growth |
| 12/08/2005 | US20050272737 Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor |
| 12/08/2005 | US20050272719 Method for inhibiting detrusor muscle overactivity |
| 12/08/2005 | US20050272717 Treatment of aromatase inhibitor therapy-related osteoporosis |
| 12/08/2005 | US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death |
| 12/08/2005 | US20050272703 Anti-tumor agents |
| 12/08/2005 | US20050272686 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 12/08/2005 | US20050272685 Intraductal treatment targeting methylated promoters in breast cancer |
| 12/08/2005 | US20050272681 Ribosome structure and protein synthesis inhibitors |
| 12/08/2005 | US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 12/08/2005 | US20050272669 treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. -[(4-{3-[N-(Carbamoylmethyl)-N-(methanesulfonyl)amino]-propoxy}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/08/2005 | US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 12/08/2005 | US20050272654 NF-kappaB activation inhibitors, and their pharmaceutical uses |
| 12/08/2005 | US20050272649 Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure |
| 12/08/2005 | US20050272642 Protecting a muscarinic acetylcholine receptor in Alzheimer patients from oxidative stress, detoxification from toxic metal, by administering at least one pyrophosphates; prevent tissue damage, increasing the efficacy of a therapeutic agent |
| 12/08/2005 | US20050272641 Therapeutic agents for diabetes |
| 12/08/2005 | US20050272639 Crystalline polymorph of the pentahydrate form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents |
| 12/08/2005 | US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 12/08/2005 | US20050272163 Separating from excipient active hematinic species present in iron-saccharidic compositions, such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex; analytical quantification by liquid chromatography and lasers of molecular characterisations; drugs |
| 12/08/2005 | US20050272161 Fixed-dried red blood cells or blood platelets carrying an active agent which, upon reconstitution, adhere to thrombogenic surfaces, undergo shape change, form a hemostatic plug, and release their granular contents |
| 12/08/2005 | US20050272152 Nutrient broth for expanding glycoprotein (CD34) expressing cells; reconstituting, repairing and regenerating tissue damage; tissue engineering |
| 12/08/2005 | US20050272090 Nucleic acid binding of multi-zinc finger transcription factors |
| 12/08/2005 | US20050271758 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 12/08/2005 | US20050271757 for alleviation of mild-to-moderate chronic venous insufficiency (CVI) of the legs |
| 12/08/2005 | US20050271744 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 12/08/2005 | US20050271716 Preparation containing basic drug |
| 12/08/2005 | US20050271713 Topical anesthetic preparation for pretreatment for upper gastrointestinal endoscopy |
| 12/08/2005 | US20050271673 Trifunctional reagent for conjugation to a biomolecule |
| 12/08/2005 | US20050271670 Treatments for cancer |
| 12/08/2005 | US20050271669 For therapy of proliferative disease |
| 12/08/2005 | US20050271661 Synergistic mixture with glucocorticoid receptors antagonist |
| 12/08/2005 | US20050271643 Bacterial strains, compositions including same and probiotic use thereof |
| 12/08/2005 | US20050271641 Method for improved breast milk feeding to reduce the risk of allergy |
| 12/08/2005 | US20050271634 Growth factor therapy mobilization of stem cells into the peripheral blood |
| 12/08/2005 | US20050271632 Methods of modulating hair growth |
| 12/08/2005 | US20050271631 Material compositions and related systems and methods for treating cardiac conditions |
| 12/08/2005 | US20050271630 Method for treating cancer |
| 12/08/2005 | US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases |
| 12/08/2005 | US20050271600 Fiber supplement |
| 12/08/2005 | US20050271551 Liquid chemical distribution method and apparatus |
| 12/08/2005 | US20050269238 Dispenser for progestin used for acute and maintenance treatment of DUB |
| 12/08/2005 | US20050268908 Medicament dispenser |
| 12/08/2005 | DE60017281T2 Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung Nomegestrol acetate and estrogen hormone-containing composition and its use |
| 12/08/2005 | DE4213005B4 Verwendung von Aromatasehemmern zur Empfängnisverhütung bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus Use of aromatase inhibitors for contraception in female primates without affecting the menstrual cycle |
| 12/08/2005 | DE102004023828A1 Lösung für die Peritonealdialyse Solution for peritoneal dialysis |
| 12/08/2005 | CA2567411A1 Transparent tissue-visualizing preparation |
| 12/08/2005 | CA2567101A1 Estrogen modulation of ifn-gamma-mediated conditions and diseases |
| 12/08/2005 | CA2566861A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 12/08/2005 | CA2565556A1 Polycationic antimicrobial therapeutic |
| 12/08/2005 | CA2564592A1 Compositions for improving breast health in women |
| 12/08/2005 | CA2564139A1 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 12/08/2005 | CA2562693A1 Reverse-turn mimetics and method relating thereto |
| 12/08/2005 | CA2509265A1 Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor |
| 12/07/2005 | EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof |
| 12/07/2005 | EP1602666A1 Novel protein and its dna |
| 12/07/2005 | EP1602380A1 Preventive/remedy for diseases in upper digestive tract |
| 12/07/2005 | EP1602375A2 Administration of products of the 5-lipoxygenase pathway for treating microbial infections |
| 12/07/2005 | EP1602371A2 Valproic acid and derivatives for the sensitisation of human cancer cells to increase efficacy in a combination therapy |
| 12/07/2005 | EP1602370A2 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 12/07/2005 | EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use |
| 12/07/2005 | EP1602367A1 Transdermal delivery system for treatment of cognitive disorders |
| 12/07/2005 | EP1601666A2 New neuropeptide y y5 receptor antagonists |
| 12/07/2005 | EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
| 12/07/2005 | EP1601379A1 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 12/07/2005 | EP1601366A1 Improved bioavailability and improved delivery of alkaline pharmaceutical drugs |
| 12/07/2005 | EP1601364A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 12/07/2005 | EP1601346A2 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method |
| 12/07/2005 | EP1601340A2 Regulation of mammalian hair growth |
| 12/07/2005 | EP1601248A2 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 12/07/2005 | EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 12/07/2005 | EP1463408A4 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 12/07/2005 | EP1439840B1 Monobactam antibacterial compounds and methods of use thereof |
| 12/07/2005 | EP1337228B1 Compositions for removing human cerumen |
| 12/07/2005 | EP1326608B1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
| 12/07/2005 | EP1307107B1 Oil/fat composition |
| 12/07/2005 | EP1290451B1 Diagnosis of alzheimer's disease using ldl receptor protein-1 |
| 12/07/2005 | EP1230551B1 Methods to identify compounds that modulate neuronal activity |
| 12/07/2005 | EP1216257B1 Compounds for the treatment of ischemia |
| 12/07/2005 | EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 12/07/2005 | EP1178812B1 Methods of making conditioned cell culture medium compositions |
| 12/07/2005 | EP1124548B1 Compositions for the treatment and prevention of cardiovascular diseases |
| 12/07/2005 | EP1117426B1 Akt compositions for enhancing survival of cardiomyocytes |
| 12/07/2005 | EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders |
| 12/07/2005 | EP1011658B1 Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 12/07/2005 | EP0998568B1 Mutant having uracil phosphoribosyl transferase activity |
| 12/07/2005 | EP0988059B1 Human quinone reductase 2 conjugates for adept and gdept |
| 12/07/2005 | EP0957917B1 Vitronectin receptor antagonists |
| 12/07/2005 | EP0794794B1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 12/07/2005 | CN1705682A Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 12/07/2005 | CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram |
| 12/07/2005 | CN1705493A Agent eleveting dendritic cell precursor level in blood |
| 12/07/2005 | CN1705472A Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 12/07/2005 | CN1704478A Methods for assessing patients with acute myeloid leukemia |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1704120A Compound biological product conposition and preparation method thereof |
| 12/07/2005 | CN1230444C Use of HIV polypeptide or peptide or polynucleotide expression construct containing HIV-cell toxicant T-lymphocyte epitope |
| 12/07/2005 | CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors |